| 1 |
Ishikura H, Fukasawa Y, Ogasawara K, et al. An AFP-producing gastric carcinoma with features of hepatic differentiation. A case report[J]. Cancer, 1985, 56(4): 840-848.
|
| 2 |
Metzgeroth G, Strobel P, Baumbusch T, et al. Hepatoid adenocarcinoma - review of the literature illustrated by a rare case originating in the peritoneal cavity[J]. Onkologie, 2010, 33(5): 263-269.
|
| 3 |
方三高, 陈真伟, 魏建国. 2021年第5 版WHO 胸部肿瘤分类[J]. 诊断病理学杂志, 2021, 28(7): 591-593.
|
| 4 |
Yang K, Jiang H, Li Q. Primary pulmonary hepatoid adenocarcinoma: A case report and review of the literature[J]. Medicine (Baltimore), 2019, 98(14): e15053.
|
| 5 |
Ishikura H, Kanda M, Ito M, et al. Hepatoid adenocarcinoma: a distinctive histological subtype of alpha-fetoprotein-producing lung carcinoma[J]. Virchows Arch A Pathol Anat Histopathol, 1990, 417(1): 73-80.
|
| 6 |
Saka H, Sakai S, Kondo N, et al. Successful resection of alpha-fetoprotein-producing lung cancer[J]. Chest, 1988, 94(4): 879-880.
|
| 7 |
Mendoza A, Voland J, Wolf P, et al. Supradiaphragmatic liver in the lung[J]. Arch Pathol Lab Med, 1986, 110(11): 1085-1086.
|
| 8 |
Xu K, Gao J, Feng L, et al. A case report of pulmonary hepatoid adenocarcinoma: promoting standardized diagnosis and treatment of the rare disease[J]. Front Immunol, 2023, 14: 1203876.
|
| 9 |
刘汉勇, 王晓玫, 成志强, 等. 肺原发性肝样腺癌临床病理观察[J/OL].中华临床医师杂志(电子版), 2014, 8(14): 2608-2612.
|
| 10 |
Mokrim M, Belbaraka R, Allaoui M ,et al. Hepatoid adenocarcinoma of the lung: A case report and literature review[J]. J Gastrointest Cancer, 2012, 43Suppl 1: S125-127.
|
| 11 |
Haninger DM, Kloecker GH, Bousamra Ii M, et al. Hepatoid adenocarcinoma of the lung: report of five cases and review of the literature[J]. Mod Pathol, 2014, 27(4): 535-542.
|
| 12 |
Tonyali O, Gonullu O, Ozturk MA, et al. Hepatoid adenocarcinoma of the lung and the review of the literature[J]. J Oncol Pharm Pract, 2020, 26(6): 1505-1510.
|
| 13 |
Grossman K, Beasley MB, Braman SS. Hepatoid adenocarcinoma of the lung: review of a rare form of lung cancer[J]. Respir Med, 2016, 119: 175-179.
|
| 14 |
Pasricha S, Grover S, Kamboj M, et al. Hepatoid adenocarcinoma of lung: A diagnostic challenge-series of six cases with histopathological, predictive molecular and PD.L1 assessment[J]. Indian J Pathol Microbiol, 2021, 64(1): 128-131.
|
| 15 |
Wang W, Li G. Incidence and prognostic factors of hepatoid adenocarcinoma: a population-based analysis[J]. Transl Cancer Res, 2020, 9(9): 5401-5410.
|
| 16 |
Hou Z, Xie J, Zhang L, et al. Hepatoid adenocarcinoma of the lung: A systematic review of the literature from 1981 to 2020[J]. Front Oncol, 2021, 11: 702216.
|
| 17 |
Mao JX, Liu C, Zhao YY, et al. Merged hepatopulmonary features in hepatoid adenocarcinoma of the lung: a systematic review[J]. Am J Transl Res, 2021, 13(3): 898-922.
|
| 18 |
Augustin G, Jelincic Z, Tentor D, et al. Hepatoid adenocarcinoma of the stomach: case report and short notes on immunohistochemical markers[J]. Acta Gastroenterol Belg, 2009, 72(2): 253-256.
|
| 19 |
Motooka Y, Yoshimoto K, Semba T, et al. Pulmonary hepatoid adenocarcinoma: report of a case[J]. Surg Case Rep, 2016, 2(1): 1.
|
| 20 |
Che YQ, Wang S, Luo Y, et al. Hepatoid adenocarcinoma of the lung: Presenting mediastinal metastasis without transfer to the liver[J]. Oncol Lett, 2014, 8(1): 105-110.
|
| 21 |
Xu SZ, Zhang XC, Jiang Q, et al. Alpha-fetoprotein-producing hepatoid adenocarcinoma of the lung responsive to sorafenib after multiline treatment: A case report[J]. World J Clin Cases, 2022, 10(28): 10236-10243.
|
| 22 |
Papatsimpas G, Kamposioras K, Goula K, et al. Hepatoid pancoast tumor. A case report and review of the literature[J]. Lung Cancer, 2012, 77(2): 239-245.
|
| 23 |
Li J, Qi H, Xu B, et al. Genomic profiles of a patient of pulmonary hepatoid adenocarcinoma with high AFP level: A case report[J]. Front Oncol, 2019, 9: 1360.
|
| 24 |
Sun JN, Zhang BL, Li LK, et al. Hepatoid adenocarcinoma of the lung without production of alpha-fetoprotein: A case report and review of the literature[J]. Oncol Lett, 2016, 12(1): 189-194.
|
| 25 |
张衎, 刘倩, 刘标, 等. 肺原发甲胎蛋白阳性肝样腺癌1例[J]. 中华结核和呼吸杂志, 2023, 46(7): 700-707.
|
| 26 |
Nagai E, Ueyama T, Yao T, et al. Hepatoid adenocarcinoma of the stomach. A clinicopathologic and immunohistochemical analysis[J]. Cancer, 1993, 72(6): 1827-1835.
|
| 27 |
Wang S, Li M, Chen H, et al. FDG PET/CT in hepatoid adenocarcinoma of the lung[J]. Clin Nucl Med, 2016, 41(7): e340-341.
|
| 28 |
Yatabe Y, Dacic S, Borczuk AC, et al. Best practices recommendations for diagnostic immunohistochemistry in lung cancer[J]. J Thorac Oncol, 2019, 14(3): 377-407.
|
| 29 |
Zhang C, Zhang J, Xu FP, et al. Genomic landscape and immune microenvironment features of preinvasive and early invasive lung adenocarcinoma[J]. J Thorac Oncol, 2019, 14(11): 1912-1923.
|
| 30 |
Broers JL, Ramaekers FC, Rot MK, et al. Cytokeratins in different types of human lung cancer as monitored by chain-specific monoclonal antibodies[J]. Cancer Res, 1988, 48(11): 3221-3229.
|
| 31 |
Rabban JT, Zaloudek CJ. A practical approach to immunohistochemical diagnosis of ovarian germ cell tumours and sex cord-stromal tumours[J]. Histopathology, 2013, 62(1): 71-88.
|
| 32 |
Mukhopadhyay S, Dermawan JK, Lanigan CP, et al. Insulinoma-associated protein 1 (INSM1) is a sensitive and highly specific marker of neuroendocrine differentiation in primary lung neoplasms: an immunohistochemical study of 345 cases, including 292 whole-tissue sections[J]. Mod Pathol, 2019, 32(1): 100-109.
|
| 33 |
Chen L, Han X, Gao Y, et al. Anti-PD-1 therapy achieved disease control after multiline chemotherapy in unresectable KRAS-positive hepatoid lung adenocarcinoma: A case report and literature review[J]. Onco Targets Ther, 2020, 13: 4359-4364.
|
| 34 |
Lei L, Yang L, Xu YY ,et al. Hepatoid adenocarcinoma of the lung: An analysis of the Surveillance, Epidemiology, and End Results (SEER) database[J]. Open Med (Wars), 2021, 16(1): 169-174.
|
| 35 |
Wu Z, Upadhyaya M, Zhu H, et al. Hepatoid adenocarcinoma: computed tomographic imaging findings with histopathologic correlation in 6 cases[J]. J Comput Assist Tomogr, 2007, 31(6): 846-852.
|
| 36 |
Carlinfante G, Foschini MP, Pasquinelli G, et al. Hepatoid carcinoma of the lung: a case report with immunohistochemical, ultrastructural and in-situ hybridization findings[J]. Histopathology, 2000, 37(1): 88-89.
|
| 37 |
Hayashi Y, Takanashi Y, Ohsawa H, et al. Hepatoid adenocarcinoma in the lung[J]. Lung Cancer, 2002, 38(2): 211-214.
|
| 38 |
Gavrancic T, Park YH. A novel approach using sorafenib in alpha fetoprotein-producing hepatoid adenocarcinoma of the lung[J]. J Natl Compr Canc Netw, 2015, 13(4): 387-391; quiz 391.
|
| 39 |
Basse V, Schick U, Gueguen P, et al. A mismatch repair-deficient hepatoid adenocarcinoma of the lung responding to anti-PD-L1 durvalumab therapy despite no PD-L1 expression[J]. J Thorac Oncol, 2018, 13(7): e120-e122.
|
| 40 |
Chen HF, Wang WX, Li XL, et al. Hepatoid adenocarcinoma of the lung with EGFR mutation and the response to tyrosine kinase inhibitors[J]. J Thorac Oncol, 2019, 14(10): e217-e219.
|
| 41 |
Khozin S, Roth MJ, Rajan A, et al. Hepatoid carcinoma of the lung with anaplastic lymphoma kinase gene rearrangement[J]. J Thorac Oncol, 2012, 7(11): e29-31.
|
| 42 |
Inagawa S, Shimazaki J, Hori M, et al. Hepatoid adenocarcinoma of the stomach[J]. Gastric Cancer, 2001, 4(1): 43-52.
|
| 43 |
Kumashiro Y, Yao T, Aishima S, et al. Hepatoid adenocarcinoma of the stomach: histogenesis and progression in association with intestinal phenotype[J]. Hum Pathol, 2007, 38(6): 857-863.
|
| 44 |
Maitra A, Murakata LA, Albores-Saavedra J. Immunoreactivity for hepatocyte paraffin 1 antibody in hepatoid adenocarcinomas of the gastrointestinal tract[J]. Am J Clin Pathol, 2001, 115(5): 689-694.
|